NEW YORK, Dec. 08, 2016 -- Medley Management Inc. (NYSE:MDLY) (“Medley”), a credit asset management firm, today announced that it was named Lender of the Year for the Core Mid-Markets category at the 8th Annual Americas M&A Atlas Awards Gala Ceremony.
“Medley is pleased to be named Lender of the Year by Global M&A Network. The award is a testament to the hard work of our investment team and the successful partnerships we share with middle market borrowers,” said Brook Taube, CEO of Medley.
About Medley
Medley is a credit-focused asset management firm offering yield solutions to retail and institutional investors. Medley’s national direct origination franchise, with over 85 people, is a premier provider of capital to the middle-market in the U.S. Medley has over $5 billion of assets under management in two business development companies, Medley Capital Corporation (NYSE:MCC) and Sierra Income Corporation, as well as private investment vehicles. Over the past 14 years, we have provided in excess of $6 billion of capital to over 350 companies across 35 industries in North America. For additional information, please visit Medley Management Inc. at www.mdly.com.
Medley LLC, the operating company of Medley Management Inc., has outstanding bonds which trade on the NYSE under the symbol (NYSE:MDLX). Medley Capital Corporation (NYSE:MCC) has outstanding bonds which trade on the NYSE under the symbols (NYSE:MCQ), (NYSE:MCV), and (NYSE:MCX).
Investor Relations Contact:
Sam Anderson
Head of Capital Markets & Risk
212-759-0777
Medley Management Inc.
Media Contact:
Liz Bruce
212-498-9197
Fitzroy Communications


RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Britain Courts Anthropic Amid US Defense Department Dispute
Apple Turns 50: From Garage Startup to AI Crossroads
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
First Western Ship Transits Strait of Hormuz Since Iran War Began
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment 



